I noticed some blood in my urine. I thought it might be due to premenopausal bleeding, but didn't have any spotting. What ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ... adverse reactions (≥20%) were stomatitis, nausea, fatigue, decreased ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...

"We are proud to have obtained approval of NERLYNX in Thailand for adults with HER2 positive ... vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, AST or ALT increase ...

The most common side effects (observed in at least 20% of patients) were nausea, stomatitis, decreased white blood cell ... plus fludarabine for adult and pediatric patients with AML or MDS as a ...

More adults have sought insight on whether they have autism in the last decade. It often happens after their children are ...